...We Welcome You to the Zenith Epigenetics Hub withIn The AGORACOM COMMUNITY!

Zenith's BET Inhibitor ZEN-3694 is Currently Being Evaluated in Multiple Oncology Clinical Trials

Free
Message: Re: BET and EZH2 Inhibitors: Novel Approaches for Targeting Cancer
Reply New Message
Back To Forum List View
Icon president BET and EZH2 Inhibitors: Novel Approaches for Targeting Cancer
1
BearDownAZ
Feb 05, 2019 05:28PM

Do I need to be a member of Pubmed in order to see these reviews? I'm unable to see anything more than a couple sentences outlining the articles.

Thanks 

tada

It was interesting in the prelude to the one where it shows 79 previous articles and publications on epigenetics. That library gets bigger every month so more and more people will have some familiarity.

5 Recommendations
Icon president Re: BET and EZH2 Inhibitors: Novel Approaches for Targeting Cancer
2
BearDownAZ
Feb 06, 2019 09:52AM
Reply New Message
Back To Forum List View
Share
Share
New Message
Please login to post a reply